Acurx Pharmaceuticals, Inc.
ACXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001736243
No open-market purchases or sales by Acurx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $185.5K in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Acurx Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 18 | 23 | +5 |
| Shares | 878.2K | 1.09M | +214.3K (+24.4%) |
| Value | $1.32M | $4.18M | +$2.86M (+217.1%) |
New holders (12)
Institutions that held Acurx Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Prospect Financial Services LLC | 255,150 | $977.2K | 0.99% |
| Susquehanna International Group, LLP | 53,553 | $205.1K | 0.00% |
| State Street Corp | 28,566 | $109.4K | 0.00% |
| Northern Trust Corp | 17,153 | $65.7K | 0.00% |
| LPL Financial LLC | 13,680 | $52.4K | 0.00% |
| Sigma Planning Corp | 10,000 | $38.3K | 0.00% |
| Cornerstone Planning Group LLC | 3,344 | $12.8K | 0.00% |
| Cutler Group LP | 2,300 | $8.00K | 0.00% |
| Advisory Services Network, LLC | 1,182 | $4.53K | 0.00% |
| JPMorgan Chase & Co | 511 | $1.96K | 0.00% |
| GPS Wealth Strategies Group, LLC | 500 | $1.92K | 0.00% |
| Bank of America Corp | 14 | $54 | 0.00% |
Sold out (7)
Institutions that held Acurx Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Armistice Capital, LLC | 500,000 | $750.0K |
| Renaissance Technologies LLC | 18,800 | $28.0K |
| Millennium Management LLC | 14,574 | $20.8K |
| Two Sigma Securities, LLC | 10,105 | $15.2K |
| Tower Research Capital LLC (TRC) | 7,097 | $10.6K |
| Anchor Investment Management, LLC | 4,500 | $6.75K |
| Group One Trading, L.P. | 600 | $858 |